Case Study

Clinical Development Technical Strategy

To advance its clinical development operations, a Top 10 global pharmaceutical corporation needed a solution need for a comprehensive strategy that harnesses the potential of emerging technologies in various divisions of their business, including portfolio delivery operations, clinical data management, biostatistics, clinical supplies, medical affairs, clinical innovation, and IT.

Company Objectives Included

  • Define strategic business goals and supporting capabilities for Clinical Development.
  • Understand and summarize the current environment, including issues, gaps, and opportunities.
  • Define a future state Clinical Development technical strategy and architecture that leverages emerging technology trends and aligns with needed capabilities and priorities.
  • Develop a 3-year implementation roadmap to optimize portfolio planning.

The well-defined, four-year roadmap provided by Astrix enabled the client to effectively budget, plan, and deploy business and IT resources to implement projects and achieve the strategic objectives.

Results Delivered

  • Achieved organizational alignment to a technical strategy that will establish a microservices-based, platform-centric, data-centric architecture.
  • Encompassed technologies like advanced data analytics, robotic process automation, machine learning, and artificial intelligence into the strategy to enable real-time learning, insightful decision-making, operational excellence, and radical process efficiency.
  • Transformed client’s ability to provide end-to-end digital engagement with patients and investigators.

 

Related Insights & Resources

image of hand pointing to validation graphic

Blog

The Strategic Guide to Computer Systems Validation (CSV) in Life Sciences

In 2025, the FDA issued 470 warning letters; a staggering 99% of these actions cited

Learn More
cell therapy image

Case Study

Modernizing Data Access and Automation Enables Fast-Tracking of Cell Therapeutics

Recent advancements in platforms and technologies are driving significant innovation in cell and gene therapies.

Learn More
a person using a laptop in a laboratory

Blog

Selecting and Making a Strategic Business Case for Veeva LIMS in Life Sciences

The life sciences industry is at a critical inflection point in 2026, as the limitations

Learn More

blog

This is a title

Type your paragraph here